Live Breaking News & Updates on Instil Bio Inc

Stay updated with breaking news from Instil bio inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Instil Bio Announces Strategic Update

Instil Bio Announces Strategic Update
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United-kingdom , Dallas , Texas , United-states , Ukraine , China , Nasdaq , Instil-bio-inc , Co-stimulatory-antigen-receptor , Private-securities-litigation-reform-act , Middle-east

Instil Bio Announces Effective Date of 1-for-20 Reverse Stock Split

DALLAS, Dec. 05, 2023 (GLOBE NEWSWIRE) Instil Bio, Inc. (“Instil” or the “Company”) (NASDAQ: TIL), a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, therapies for ....

Dallas , Texas , United-states , Nasdaq , Instil-bio-inc , Company-quarterly-report-on-form , Nasdaq-capital-market , Nasdaq-capital , Co-stimulatory-antigen-receptor , Private-securities-litigation-reform-act , Quarterly-report

Instil Bio Inc. (TIL) Announces Effective Date of 1-for-20 Reverse Stock Split

Instil Bio Inc. (TIL) Announces Effective Date of 1-for-20 Reverse Stock Split
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Instil-bio-inc , Instil-bio , Nasdaq-capital-market , Nasdaq-capital ,

Instil Bio Announces Effective Date of 1-for-20 Reverse Stock Split

Instil Bio Announces Effective Date of 1-for-20 Reverse Stock Split
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Dallas , Texas , United-states , Nasdaq , Company-quarterly-report-on-form , Instil-bio-inc , Bio-announces-effective-date , Nasdaq-capital-market , Nasdaq-capital , Co-stimulatory-antigen-receptor , Private-securities-litigation-reform-act